Vivos Therapeutics (VVOS) Treasury Shares (2019)

Vivos Therapeutics' (VVOS) quarterly Treasury Shares came in at $730000.0 in Q4 2019.

Vivos Therapeutics (VVOS) Treasury Shares (2019) Analysis & Trends

Vivos Therapeutics (VVOS) has 1 years of Treasury Shares data on file, last reported at $730000.0 in Q4 2019.

  • On a quarterly basis, Treasury Shares changed N/A year-over-year to $730000.0 in Q4 2019; TTM through Dec 2019 was $730000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $730000.0, changed N/A from the prior year.
  • Treasury Shares for Q4 2019 stood at $730000.0.
  • Over the last five years, Treasury Shares for VVOS reached as high as $730000.0 in Q4 2019 and fell as low as $730000.0 in Q4 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 16.94 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 7.70 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 83.00 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 14.05 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 4.51 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 515.00 Mn
10 Vivos Therapeutics 3.62 Mn 1.38 Mn 3.06 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 730,000.00
Dec 31, 2019 730,000.00